Solici Eliminates Research Bottlenecks with AlphaSense

Solici, the competitive-intelligence arm of Cambridge Healthcare Research serving pharma clients across oncology, rare disease and infectious disease, had research delays because AlphaSense access was limited across its 100+ analyst team. It expanded licenses company-wide to remove data-retrieval and manual note-taking bottlenecks. The page states this freed up eight hours weekly per analyst for higher-value strategic work, helped achieve 10+ year client retention, and let analysts rapidly upskill on new topics while maintaining credibility with clients in the fast-moving life sciences sector.

AlphaSense is an AI-powered search platform over premium business documents, earnings calls, filings and expert-network transcripts, used by pharma competitive-intelligence and business-development teams.

This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.